European Union: EU Medical Device Regulation 2017/745 And In Vitro Diagnostic Regulation 2017/746

Following their adoption by the European Parliament in April 2017, the final versions of the Medical Devices Regulation ("MDR") and In Vitro Diagnostic Regulation ("IVDR") were published in the Official Journal of the European Union on May 5, 2017. The Regulations will enter into force on May 25, 2017, and will become fully applicable following a transitional period of three and five years, respectively. The MDR will apply as of May 26, 2020, and the IVDR will apply as of May 26, 2022. Both Regulations make some exceptions for early application as well as additional transitional periods.

These Regulations will replace the current Medical Devices Directive (93/42/EC on medical devices), the Active Implantable Medical Devices Directive (90/385/EC on active implantable medical devices ), and the In Vitro Diagnostics Directive (98/79/EC on in vitro diagnostic ("IVD") medical devices). The new Regulations are designed to improve the quality, safety, and reliability of medical devices and in vitro diagnostics; to strengthen transparency of consumer information; and to enhance vigilance and market surveillance while supporting innovation.

Summary of the Key Changes

Below is a high-level summary of some of the key changes brought by the MDR and IVDR to the regulatory framework applicable to medical devices.

Inclusion of Products Without Medical Purpose and New Classification Rules. Certain groups of products that do not have an intended medical purpose but that present a risk profile similar to medical devices have been included in the scope of the new MDR. Examples include contact lenses; facial, dermal, or mucous membrane filling substances or articles; and liposuction equipment and laser equipment for skin treatment. For IVDs, entirely new risk-based classification rules have been introduced by the IVDR. Beginning May 26, 2022, IVD medical devices will have to be categorized in classes A to D.

New Post-Market Clinical Requirements. As of the date of application of the new Regulations, medical device manufacturers will be required to include a post-market clinical follow-up or post-market performance follow-up (for IVDs) in their post-market surveillance system in order to continuously update the clinical evaluation of the device. For implantable and class III devices, a summary of safety and clinical performance must be drawn up by manufacturers and validated by notified bodies before being made publicly available.

Stricter Rules for Notified Bodies. All notified bodies will have to be redesignated under the MDR/IVDR and comply with all requirements laid down in the respective Annex VII of the new Regulations. Notified bodies must employ medically trained staff and, among other things, must have documented procedures regarding unannounced on-site audits of manufacturers and, where applicable, of subcontractors and suppliers. The MDR and IVDR also introduce a mechanism for scrutiny of certain high-risk medical devices. Under this procedure, a manufacturer's notified body will be required to notify the competent authorities of certificates it has granted for such high-risk devices. The competent authorities and, where applicable, the European Commission may request scientific advice from expert panels in relation to the safety and performance of any device, based on its reasonable concerns.

Introduction of the Unique Device Identification ("UDI") System. The new Regulations enhance traceability requirements of medical devices throughout the supply chain by requiring that a UDI be affixed to a medical device or to its packaging. Each component that is considered a device and is commercially available on its own will be assigned a separate UDI.

Joint Responsibility of Authorized Representatives. Non-EU manufacturers of medical devices and IVDs must appoint a European Authorized Representative in the European Union. Under the new Regulations, the European Authorized Representative will be responsible for verifying that the EU Declaration of Conformity and technical documentation have been drawn up by the manufacturer and, where applicable, that an appropriate conformity assessment procedure has been conducted. Most importantly, the European Authorized Representative would be legally liable, jointly and severally, with the manufacturer, for defective devices placed on the EU market if the medical devices are not compliant with the Regulations' requirements.

Increased Transparency. The UDI, along with post-market vigilance data and ongoing clinical investigations, must be entered into the European Databank on Medical Devices ("EUDAMED"), which will become accessible to the public. The EUDAMED database is expected to be put into place by 2020.

Transitional Provisions

The two Regulations include transitional provisions permitting CE Certificates of Conformity issued by notified bodies in accordance with the current Directives and prior to May 25, 2017, to remain valid until the end of the period indicated on the Certificates. Notified bodies will also be allowed to issue CE Certificates of Conformity in accordance with the current Directives after May 25, 2017. These Certificates will be issued for a period of validity not exceeding five years and will become void at the latest on May 27, 2024.

It should be noted that medical devices to which these Certificates relate may be placed on the EU market or put into service in the European Union only if, from May 26, 2020, or May 26, 2022, as the case may be, they remain in compliance with the relevant current Directives, and provided there are no significant changes in the design and intended purpose of the medical devices. Moreover, there will be related changes in some obligations related to the devices. The requirements of the MDR and IVDR relating to post-market surveillance, market surveillance, vigilance, and registration of economic operators and of devices will apply in place of the corresponding requirements in the Medical Device and In Vitro Diagnostic Directives.

Conclusion

Medical devices that comply with the MDR may be placed on the EU market before the MDR date of application (anticipated in May 2020) if they have been audited by a notified body designated under the MDR. Notified bodies can apply for redesignation from six months after the regulations take effect. They can test for compliance with the MDR requirements only once they have been redesignated. It has been reported that this process could take up to 18 months from the date of application for redesignation.

Therefore, in addition to monitoring the validity of their Certificates of Conformity, medical device manufacturers should ensure as soon as possible that their notified bodies will be redesignated or otherwise, initiate the process of contracting with a notified body that meets the new requirements of the new Regulations and will therefore be redesignated quickly.

In addition, the European Commission is set to adopt approximately 80 delegated and implementing acts to further specify applicable requirements and obligations under the new Regulations. Manufacturers of medical devices and in vitro diagnostics should monitor closely relevant developments.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Christian Fulda
Colleen Heisey
Indradeep Bhattacharya
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.